Displaying drugs 751 - 775 of 4257 in total
Carbetocin
Carbetocin is a drug used to control postpartum hemorrhage, bleeding after giving birth. It is an analogue of oxytocin, and its action is similar to that of oxytocin -- it causes contraction of the uterus.
Approved
Investigational
Matched Synonyms: … 1-butyric acid-2-(3-(p-methoxyphenyl)-L-alanine)oxytocin ... 1-butanoic acid-2-(O-methyl-L-tyrosine)-1-carbaoxytocin …
Matched Iupac: … 5,8,11,14,17-pentaoxo-1-thia-4,7,10,13,16-pentaazacycloicosane-3-carbonyl]pyrrolidin-2-yl]formamido}-N- …
Matched Description: … It is an analogue of oxytocin, and its action is similar to that of oxytocin -- it causes contraction …
Matched Categories: … Amino Acids, Peptides, and Proteins ... Pituitary and Hypothalamic Hormones and Analogues ... Oxytocin and Analogues ... Hormones, Hormone Substitutes, and Hormone Antagonists ... Sex Hormones and Insulins …
Matched Iupac: … 5,8,11,14,17-pentaoxo-1-thia-4,7,10,13,16-pentaazacycloicosane-3-carbonyl]pyrrolidin-2-yl]formamido}-N- …
Matched Description: … It is an analogue of oxytocin, and its action is similar to that of oxytocin -- it causes contraction …
Matched Categories: … Amino Acids, Peptides, and Proteins ... Pituitary and Hypothalamic Hormones and Analogues ... Oxytocin and Analogues ... Hormones, Hormone Substitutes, and Hormone Antagonists ... Sex Hormones and Insulins …
N-[Isoleucinyl]-N'-[adenosyl]-diaminosufone
Experimental
Matched Name: … N-[Isoleucinyl]-N'-[adenosyl]-diaminosufone …
Matched Iupac: … (2S,3S)-2-amino-N-({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl}sulfamoyl …
Matched Iupac: … (2S,3S)-2-amino-N-({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl}sulfamoyl …
m-Hydroxyhippuric acid
Experimental
Matched Synonyms: … N-m-Hydroxylbenzoylglycine ... 3-hydroxyhippuric acid ... 2-[(3-hydroxyphenyl)formamido]acetic acid …
Matched Name: … m-Hydroxyhippuric acid …
Matched Iupac: … 2-[(3-hydroxyphenyl)formamido]acetic acid …
Matched Categories: … Benzamides and benzamide derivatives ... Acids, Carbocyclic ... Keto Acids ... Carboxylic Acids …
Matched Name: … m-Hydroxyhippuric acid …
Matched Iupac: … 2-[(3-hydroxyphenyl)formamido]acetic acid …
Matched Categories: … Benzamides and benzamide derivatives ... Acids, Carbocyclic ... Keto Acids ... Carboxylic Acids …
N-[O-Phosphono-Pyridoxyl]-Isoleucine
Experimental
Matched Name: … N-[O-Phosphono-Pyridoxyl]-Isoleucine …
Matched Iupac: … 2R,3S)-2-[({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methyl)amino]-3-methylpentanoic acid …
Matched Iupac: … 2R,3S)-2-[({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methyl)amino]-3-methylpentanoic acid …
N-Pyridoxyl-Glycine-5-Monophosphate
Experimental
Matched Name: … N-Pyridoxyl-Glycine-5-Monophosphate …
Matched Iupac: … 2-[({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methyl)amino]acetic acid …
Matched Iupac: … 2-[({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methyl)amino]acetic acid …
Vodudeutentan
Investigational
Matched Synonyms: … BQ-788 free acid, di(methyl-d)- ... d-tryptophyl- ... D-norleucine, n-((cis-2,6-di(methyl-d)-1-piperidinyl)carbonyl)-4-methyl-l-leucyl-1-(methoxycarbonyl)- …
Matched Iupac: … -carbonyl]amino}-4,4-dimethylpentanamido]-3-[1-(methoxycarbonyl)-1H-indol-3-yl]propanamido]hexanoic acid …
Matched Iupac: … -carbonyl]amino}-4,4-dimethylpentanamido]-3-[1-(methoxycarbonyl)-1H-indol-3-yl]propanamido]hexanoic acid …
Chlorambucil
A nitrogen mustard alkylating agent used as antineoplastic agent for the treatment of various malignant and nonmalignant diseases. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
Approved
Matched Synonyms: … N,N-di-2-chloroethyl-γ-p-aminophenylbutyric acid ... N,N-di-2-chloroethyl-gamma-p-aminophenylbutyric acid ... Phenylbutyric acid nitrogen mustard …
Matched Iupac: … 4-{4-[bis(2-chloroethyl)amino]phenyl}butanoic acid …
Matched Description: … nitrogen mustard alkylating agent used as antineoplastic agent for the treatment of various malignant and ... nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP …
Matched Categories: … Antineoplastic and Immunomodulating Agents …
Matched Iupac: … 4-{4-[bis(2-chloroethyl)amino]phenyl}butanoic acid …
Matched Description: … nitrogen mustard alkylating agent used as antineoplastic agent for the treatment of various malignant and ... nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP …
Matched Categories: … Antineoplastic and Immunomodulating Agents …
N-Pyridoxyl-Threonine-5-Monophosphate
Experimental
Matched Name: … N-Pyridoxyl-Threonine-5-Monophosphate …
Matched Iupac: … 3-hydroxy-2-[({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methyl)amino]butanoic acid …
Matched Iupac: … 3-hydroxy-2-[({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methyl)amino]butanoic acid …
OM-301
Investigational
Matched Synonyms: … Glycine, L-prolyl-L-prolyl-L-leucyl-L-seryl-L-glutaminyl-L-alpha-glutamyl-L-threonyl-Lphenylalanyl- L-seryl-L-alpha-aspartyl-L-leucyl-L-tryptophyl-L-lysyl-L-leucyl-L-leucyl-L-lysyl-Llysyl ... - L-tryptophyl-L-lysyl-L-methionyl-L-arginyl-L-arginyl-L-asparaginy …
Mafenide
Mafenide is a sulfonamide-type antimicrobial agent used to treat severe burns. It acts by reducing the bacterial population present in the burn tissue and promotes healing of deep burns. In 1998, mafenide acetate was approved under the FDA’s accelerated approval regulations. In November 2022, the use of mafenide acetate (powder...
Approved
Vet approved
Withdrawn
Matched Description: … It acts by reducing the bacterial population present in the burn tissue and promotes healing of deep ... [L36773] In 1998, mafenide acetate was approved under the FDA’s accelerated approval regulations. ... In November 2022, the use of mafenide acetate (powder for 5% topical solution) was withdrawn by the FDA …
Matched Salts name: … Mafenide Acetate …
Matched Categories: … Folic Acid Antagonists ... Genito Urinary System and Sex Hormones ... Gynecological Antiinfectives and Antiseptics …
Matched Products: … Mafenide acetate ... Mafenide Acetate …
Matched Salts name: … Mafenide Acetate …
Matched Categories: … Folic Acid Antagonists ... Genito Urinary System and Sex Hormones ... Gynecological Antiinfectives and Antiseptics …
Matched Products: … Mafenide acetate ... Mafenide Acetate …
Denosumab
Denosumab is a novel, fully human IgG2 monoclonal antibody specific to receptor activator of nuclear factor kappa-B ligand (RANKL), suppresses bone resorption via inhibiting RANK-mediated activation of osteoclasts. It is the first and currently the only RANKL inhibitor approved to prevent osteoclast-mediated bone loss. Chemically, it consists of 2 heavy...
Approved
Matched Description: … 215 amino acids and each heavy chain consisting of 448 amino acids with 4 intramolecular disulfides. ... It is the first and currently the only RANKL inhibitor approved to prevent osteoclast-mediated bone loss ... [A263071] Chemically, it consists of 2 heavy and 2 light chains, with each light chain consisting of …
Matched Categories: … Amino Acids, Peptides, and Proteins ... Drugs Affecting Bone Structure and Mineralization …
Matched Products: … Prolia ... PROLIA ... PROLIA® …
Matched Categories: … Amino Acids, Peptides, and Proteins ... Drugs Affecting Bone Structure and Mineralization …
Matched Products: … Prolia ... PROLIA ... PROLIA® …
alpha-Methylleucine
Experimental
Matched Synonyms: … 2-Methyl-L-leucine …
Matched Iupac: … (2S)-2-amino-2,4-dimethylpentanoic acid …
Matched Iupac: … (2S)-2-amino-2,4-dimethylpentanoic acid …
3-Cyclohexyl-L-alanine
Experimental
Matched Synonyms: … β-Cyclohexyl-alanine ... beta-Cyclohexyl-alanine ... beta-Cyclohexyl-L-alanine …
Matched Name: … 3-Cyclohexyl-L-alanine …
Matched Iupac: … (2S)-2-amino-3-cyclohexylpropanoic acid …
Matched Name: … 3-Cyclohexyl-L-alanine …
Matched Iupac: … (2S)-2-amino-3-cyclohexylpropanoic acid …
2-Hydroxy-Tryptophan
Experimental
Matched Name: … 2-Hydroxy-Tryptophan …
Matched Iupac: … (2S)-2-amino-3-(2-hydroxy-1H-indol-3-yl)propanoic acid …
Matched Iupac: … (2S)-2-amino-3-(2-hydroxy-1H-indol-3-yl)propanoic acid …
Lysergic acid diethylamide
Debate continues over the nature and causes of chronic flashbacks. Explanations in terms of LSD physically remaining in the body for months or years after consumption have been discounted by experimental evidence. Some say HPPD is a manifestation of post-traumatic stress disorder, not related to the direct action of LSD...
Illicit
Investigational
Withdrawn
Matched Synonyms: … D-lysergic acid diethylamide ... Lysergic acid diethylamide ... N,N-diethyllysergamide …
Matched Name: … Lysergic acid diethylamide …
Matched Iupac: … (4R,7R)-N,N-diethyl-6-methyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(16),2,9,12,14-pentaene …
Matched Description: … Debate continues over the nature and causes of chronic flashbacks. ... of LSD on brain chemistry, and varies according to the susceptibility of the individual to the disorder ... Some say HPPD is a manifestation of post-traumatic stress disorder, not related to the direct action …
Matched Categories: … Ergot Alkaloids and Derivatives ... Lysergic Acid …
Matched Name: … Lysergic acid diethylamide …
Matched Iupac: … (4R,7R)-N,N-diethyl-6-methyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(16),2,9,12,14-pentaene …
Matched Description: … Debate continues over the nature and causes of chronic flashbacks. ... of LSD on brain chemistry, and varies according to the susceptibility of the individual to the disorder ... Some say HPPD is a manifestation of post-traumatic stress disorder, not related to the direct action …
Matched Categories: … Ergot Alkaloids and Derivatives ... Lysergic Acid …
Indoximod
Indoximod has been used in trials studying the treatment of Glioma, Melanoma, Ependymoma, Gliosarcoma, and Lung Cancer, among others.
Investigational
Matched Synonyms: … (2R)-2-amino-3-(1-methyl-1H-indol-3-yl)propanoic acid ... 1-methyl-D-tryptophan …
Matched Iupac: … (2R)-2-amino-3-(1-methyl-1H-indol-3-yl)propanoic acid …
Matched Description: … Indoximod has been used in trials studying the treatment of Glioma, Melanoma, Ependymoma, Gliosarcoma, and …
Matched Categories: … Amino Acids, Peptides, and Proteins ... Tryptophan Oxygenase, antagonists & inhibitors ... Amino Acids ... Amino Acids, Cyclic ... Amino Acids, Aromatic …
Matched Iupac: … (2R)-2-amino-3-(1-methyl-1H-indol-3-yl)propanoic acid …
Matched Description: … Indoximod has been used in trials studying the treatment of Glioma, Melanoma, Ependymoma, Gliosarcoma, and …
Matched Categories: … Amino Acids, Peptides, and Proteins ... Tryptophan Oxygenase, antagonists & inhibitors ... Amino Acids ... Amino Acids, Cyclic ... Amino Acids, Aromatic …
N(6)-(pyridoxal phosphate)-L-lysine
Experimental
Matched Synonyms: … N6-((3-Hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinyl)methylene)-L-lysine ... (S)-2-amino-6-[(3-hydroxy-2-methyl-5-phosphonooxymethyl-4-pyridine)methyleneamino]hexanoic acid …
Matched Name: … N(6)-(pyridoxal phosphate)-L-lysine …
Matched Iupac: … 2-amino-6-[(E)-({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methylidene)amino]hexanoic acid …
Matched Name: … N(6)-(pyridoxal phosphate)-L-lysine …
Matched Iupac: … 2-amino-6-[(E)-({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methylidene)amino]hexanoic acid …
2,3-Dimercapto-1-propanesulfonic acid
Experimental
Matched Synonyms: … 2,3-Dimercaptopropanesulfonic acid ... 2,3-Dimercapto-1-propane sulfonate …
Matched Name: … 2,3-Dimercapto-1-propanesulfonic acid …
Matched Iupac: … 2,3-disulfanylpropane-1-sulfonic acid …
Matched Name: … 2,3-Dimercapto-1-propanesulfonic acid …
Matched Iupac: … 2,3-disulfanylpropane-1-sulfonic acid …
Furoyl-Leucine
Experimental
Matched Name: … Furoyl-Leucine …
Matched Iupac: … (2S)-2-[(furan-2-yl)formamido]-4-methylpentanoic acid …
Matched Iupac: … (2S)-2-[(furan-2-yl)formamido]-4-methylpentanoic acid …
D-Methionine
Approved
Experimental
Investigational
Matched Name: … D-Methionine …
Matched Iupac: … (2R)-2-amino-4-(methylsulfanyl)butanoic acid …
Matched Mixtures name: … NUTRINEAL PD]4 Peritoneal Dialysis Solution with 1.1% Amino Acids …
Matched Iupac: … (2R)-2-amino-4-(methylsulfanyl)butanoic acid …
Matched Mixtures name: … NUTRINEAL PD]4 Peritoneal Dialysis Solution with 1.1% Amino Acids …
Imino-Tryptophan
Experimental
Matched Name: … Imino-Tryptophan …
Matched Iupac: … 2-imino-3-(1H-indol-3-yl)propanoic acid …
Matched Iupac: … 2-imino-3-(1H-indol-3-yl)propanoic acid …
N-{[6-(PENTYLOXY)NAPHTHALEN-2-YL]SULFONYL}-D-GLUTAMIC ACID
Experimental
Matched Name: … N-{[6-(PENTYLOXY)NAPHTHALEN-2-YL]SULFONYL}-D-GLUTAMIC ACID …
Matched Iupac: … (2R)-2-[6-(pentyloxy)naphthalene-2-sulfonamido]pentanedioic acid …
Matched Iupac: … (2R)-2-[6-(pentyloxy)naphthalene-2-sulfonamido]pentanedioic acid …
PARA-NITROBENZYL GLUTARYL GLYCINIC ACID
Experimental
Matched Name: … PARA-NITROBENZYL GLUTARYL GLYCINIC ACID …
Matched Iupac: … 2-(4-{[(4-nitrophenyl)methyl]carbamoyl}butanamido)acetic acid …
Matched Iupac: … 2-(4-{[(4-nitrophenyl)methyl]carbamoyl}butanamido)acetic acid …
Pegargiminase
Pegargiminase is an anticancer agent.
Investigational
Matched Synonyms: … Arginine deiminase pegylated ... Pegylated arginine deiminase …
Matched Categories: … Enzymes and Coenzymes …
Matched Categories: … Enzymes and Coenzymes …
Hydroxyurea
Hydroxyurea is a non-alkylating antineoplastic agent that was first synthesized in 1869 but was not characterized biologically until 1928. It was first approved by the FDA in 1998 for the treatment of sickle cell anemia in adults. Although clinical evidence on the efficacy of hydroxyurea in certain conditions exists, hydroxyurea...
Approved
Matched Synonyms: … Carbamohydroxamic acid ... Carbamohydroximic acid ... N-Hydroxyurea …
Matched Description: … adherence, the need for therapeutic monitoring, and serious side effects of secondary cancer and birth ... conditions exists, hydroxyurea is used sparingly in clinical settings, largely due to lack of knowledge and ... Hydroxyurea is a non-alkylating antineoplastic agent that was first synthesized in 1869 but was not characterized …
Matched Categories: … Antineoplastic and Immunomodulating Agents ... Nucleic Acid Synthesis Inhibitors …
Matched Description: … adherence, the need for therapeutic monitoring, and serious side effects of secondary cancer and birth ... conditions exists, hydroxyurea is used sparingly in clinical settings, largely due to lack of knowledge and ... Hydroxyurea is a non-alkylating antineoplastic agent that was first synthesized in 1869 but was not characterized …
Matched Categories: … Antineoplastic and Immunomodulating Agents ... Nucleic Acid Synthesis Inhibitors …
Displaying drugs 751 - 775 of 4257 in total